Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,645
Closed -$241K 467
2017
Q4
$241K Sell
5,645
-3,860
-41% -$154K 0.01% 425
2017
Q3
$349K Sell
9,505
-700
-7% -$28.3K 0.01% 356
2017
Q2
$463K Hold
10,205
0.02% 299
2017
Q1
$434K Buy
10,205
+700
+7% +$28.5K 0.02% 311
2016
Q4
$381K Hold
9,505
0.02% 312
2016
Q3
$369K Hold
9,505
0.02% 316
2016
Q2
$329K Hold
9,505
0.01% 330
2016
Q1
$328K Hold
9,505
0.01% 328
2015
Q4
$368K Hold
9,505
0.02% 308
2015
Q3
$372K Sell
9,505
-6,340
-40% -$251K 0.02% 303
2015
Q2
$603K Sell
15,845
-540
-3% -$18.9K 0.03% 258
2015
Q1
$541K Hold
16,385
0.02% 272
2014
Q4
$438K Hold
16,385
0.02% 293
2014
Q3
$399K Sell
16,385
-800
-5% -$20.2K 0.02% 297
2014
Q2
$436K Sell
17,185
-1,740
-9% -$40.7K 0.02% 285
2014
Q1
$412K Hold
18,925
0.02% 290
2013
Q4
$423K Hold
18,925
0.02% 275
2013
Q3
$391K Sell
18,925
-1,800
-9% -$38.3K 0.02% 284
2013
Q2
$400K Buy
+20,725
New +$433K 0.02% 264

Other funds holding HOLX

Gofen & Glossberg's HOLX Position: Q1 2018 in Review

Gofen & Glossberg sold out of Hologic (HOLX) in Q1 2018, closing a stake of 5,645 shares — an estimated $241K sold.

Gofen & Glossberg first reported a position in HOLX in Q2 2013 and held it in 19 quarters. The position peaked at $603K in Q2 2015. 462 funds tracked by Wall St. Rank hold HOLX as of Q1 2018.

  • Gofen & Glossberg reported no remaining Hologic position as of Q1 2018 after selling out during the quarter.
  • Gofen & Glossberg sold 5,645 Hologic shares in Q1 2018, an estimated $241K.
  • Gofen & Glossberg first reported a position in Hologic in Q2 2013 and held it in 19 quarters.
  • Gofen & Glossberg's Hologic position peaked at $603K in Q2 2015.
  • 462 funds tracked by Wall St. Rank held Hologic as of Q1 2018.

Based on Gofen & Glossberg's 13F filing for Q1 2018, filed 11 Apr 2018.